Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

BackgroundRanolazine (Rn), an antianginal agent, acts in the central nervous system and has been used as a potential treatment agent for pain and epileptic disorders. Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases and the leading factor in dementia in the elderly.Ai...

ver descrição completa

Detalhes bibliográficos
Principais autores: Shereen M. Samir, Hend M. Hassan, Rasha Elmowafy, Eman Mohamed ElNashar, Mansour Abdullah Alghamdi, Mona Hmoud AlSheikh, Norah Saeed Al-Zahrani, Faten Mohammed Alasiri, Mona G. Elhadidy
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2024-01-01
coleção:Frontiers in Neuroscience
Assuntos:
ranolazine
scopolamine
dementia
apoptosis
GFAP
tau
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fnins.2023.1267675/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2023.1267675/full

Registros relacionados